Quick Answer
aTYR PHARMA INC reported Total Revenue of $190.0 thousand for fiscal year 2025.
aTYR PHARMA INC Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $190.0K | -19.1% |
| 2024 | $235.0K | -33.4% |
| 2023 | $353.0K | -96.6% |
| 2022 | $10.39M | — |
| 2021 | $0.00 | -100.0% |
| 2020 | $10.46M | +2377.5% |
| 2019 | $422.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $190.0K | — | — |
| June 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | -100.0% | — |
| September 30, 2024 | $0.00 | -100.0% | — |
| June 30, 2024 | $0.00 | — | -100.0% |
| March 31, 2024 | $235.0K | — | -33.4% |
| September 30, 2023 | $353.0K | — | — |
| June 30, 2023 | $0.00 | — | — |
- aTYR PHARMA INC showed a decrease of -19.1% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, aTYR PHARMA INC’s total revenue has declined by 55.0% (from $422.0 thousand to $190.0 thousand).
- The most recent figure is from aTYR PHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: